Sema Zergeroğlu

ORCID: 0000-0003-2348-7379 · 7 papers in corpus
article 2014
article 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.06.029

ObjectiveTo determine the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in the rat endometriosis model.Study designA randomized, placebo-controlled, blinded study using rat endometriosis model. After…

article 2010
Archives of gynecology and obstetrics ·doi:10.1007/s00404-010-1434-0

ObjectiveTo show the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in an experimental model.DesignA randomized, placebo-controlled, blinded study using rat endometriosis model.SettingExperimental res…

letter 2006
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.07.1527

The effect of immunomodulator leflunomide on the development of an experimental endometriosis model was assessed by surgically transplanting autologous fragments of endometrial tissue onto the inner surface of the abdominal wall and arteria…

article 2006
Journal of the Society for Gynecologic Investigation ·doi:10.1016/j.jsgi.2006.03.006

ObjectiveTo test if leflunomide, an immunomodulator, could impede the growth of an ectopic uterine tissue.MethodsEndometriosis was surgically induced in 26 rats by transplanting an autologous fragment of endometrial tissue onto the inner su…

article 2002
·doi:10.16948/zktb.45584

Objective : The aim of this study is the correlation of clinical findings, ultrasonographic findings and postlaparoscopic pathological findings of 627 patients who were prediagnosed as endometrioma in the recent one year period in our hospi…

article 1998
·doi:10.16948/zktb.48919